Home › Cardiovascular Disease › Alabama › Birmingham
Cardiovascular Disease clinical trials in Birmingham, AL
16 studies for Cardiovascular Disease are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Birmingham
- Clinical Trial Site, Birmingham
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- University of Alabama Birmingham (UAB) Hospital, Birmingham
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Cardiology, PC, Birmingham
Product Surveillance Registry
RecruitingObservational study
- Birmingham, Birmingham
Zenith® Fenestrated+ Clinical Study
Recruiting
- University of Alabama Birmingham Hospital, Birmingham
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
RecruitingHealthy volunteers welcome
- University of Alabama at Birmingham, Birmingham
Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk
Recruiting
- University of Alabama at Birmingham, Birmingham
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- University of Alabama at Birmingham, Birmingham
- Birmingham VA, Birmingham
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Birmingham
- Research Site, Birmingham
- Research Site, Irondale · 6 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- University of Alabama Birmingham Saint Vincents Birmingham, Birmingham
- Birmingham Clinical Research, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
RecruitingObservational study
- Cooper Green Mercy Hospital, Birmingham
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
RecruitingPhase 2Healthy volunteers welcome
- University of Alabama at Birmingham, Birmingham
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
RecruitingPhase 2/3Healthy volunteers welcome
- University of Alabama at Birmingham, Birmingham
CARBON: UAB Cardiovascular Research Biobank
RecruitingObservational studyHealthy volunteers welcome
- University of Alabama at Birmingham, Birmingham
Inspire HER: Inspiring the Heart and Emotions for Radical Health
Recruiting
- University of Alabama at Birmingham, Birmingham
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Recruiting
- Cardiology, PC - Princeton Baptist Medical Center, Birmingham
Cardiovascular Disease trials in other cities
- Boston, MA34 studies
- New York City, NY30 studies
- Washington, DC27 studies
- Dallas, TX24 studies
- Houston, TX22 studies
- Philadelphia, PA22 studies
- Pittsburgh, PA21 studies
- St. Louis, MO20 studies
- Cleveland, OH20 studies
- San Francisco, CA20 studies
- Chicago, IL20 studies
- Atlanta, GA20 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Ovarian Cancer25 studies
- Breast Cancer24 studies
- Non-Small Cell Lung Cancer23 studies
- Obesity22 studies
- Acute Myeloid Leukemia21 studies
- COPD17 studies
- Multiple Myeloma17 studies
- Endometrial Cancer16 studies
- Overweight16 studies
- Type 2 Diabetes16 studies
- Cystic Fibrosis15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.